190 related articles for article (PubMed ID: 28684541)
21. Mitotic slippage and the subsequent cell fates after inhibition of Aurora B during tubulin-binding agent-induced mitotic arrest.
Tsuda Y; Iimori M; Nakashima Y; Nakanishi R; Ando K; Ohgaki K; Kitao H; Saeki H; Oki E; Maehara Y
Sci Rep; 2017 Dec; 7(1):16762. PubMed ID: 29196757
[TBL] [Abstract][Full Text] [Related]
22. Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate.
Orth JD; Tang Y; Shi J; Loy CT; Amendt C; Wilm C; Zenke FT; Mitchison TJ
Mol Cancer Ther; 2008 Nov; 7(11):3480-9. PubMed ID: 18974392
[TBL] [Abstract][Full Text] [Related]
23. Clinical Development of Anti-mitotic Drugs in Cancer.
Olziersky AM; Labidi-Galy SI
Adv Exp Med Biol; 2017; 1002():125-152. PubMed ID: 28600785
[TBL] [Abstract][Full Text] [Related]
24. High LET radiation enhances nocodazole Induced cell death in HeLa cells through mitotic catastrophe and apoptosis.
Li P; Zhou L; Dai Z; Jin X; Liu X; Matsumoto Y; Furusawa Y; Li Q
J Radiat Res; 2011; 52(4):481-9. PubMed ID: 21785236
[TBL] [Abstract][Full Text] [Related]
25. Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.
Dalton WB; Yang VW
Future Oncol; 2009 Nov; 5(9):1363-70. PubMed ID: 19903065
[TBL] [Abstract][Full Text] [Related]
26. The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs.
Visconti R; Della Monica R; Palazzo L; D'Alessio F; Raia M; Improta S; Villa MR; Del Vecchio L; Grieco D
Cell Death Differ; 2015 Sep; 22(9):1551-60. PubMed ID: 25744022
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.
Vogel C; Kienitz A; Hofmann I; Müller R; Bastians H
Oncogene; 2004 Sep; 23(41):6845-53. PubMed ID: 15286707
[TBL] [Abstract][Full Text] [Related]
29. Universal response in the RKO colon cancer cell line to distinct antimitotic therapies.
Lorz A; Botesteanu DA; Levy D
Sci Rep; 2018 Jun; 8(1):8979. PubMed ID: 29895957
[TBL] [Abstract][Full Text] [Related]
30. Resistance to anti-microtubule drug-induced cell death is determined by regulation of BimEL expression.
Ruan W; Venkatachalam G; Sobota RM; Chen L; Wang LC; Jacobson A; Paramasivam K; Surana U
Oncogene; 2019 May; 38(22):4352-4365. PubMed ID: 30770899
[TBL] [Abstract][Full Text] [Related]
31. Nocodazole induces mitotic cell death with apoptotic-like features in Saccharomyces cerevisiae.
Endo K; Mizuguchi M; Harata A; Itoh G; Tanaka K
FEBS Lett; 2010 Jun; 584(11):2387-92. PubMed ID: 20399776
[TBL] [Abstract][Full Text] [Related]
32. Mitosis is not a key target of microtubule agents in patient tumors.
Komlodi-Pasztor E; Sackett D; Wilkerson J; Fojo T
Nat Rev Clin Oncol; 2011 Feb; 8(4):244-50. PubMed ID: 21283127
[TBL] [Abstract][Full Text] [Related]
33. Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments.
Scott SJ; Li X; Jammula S; Devonshire G; Lindon C; Fitzgerald RC; D'Avino PP
Cell Death Differ; 2021 Jul; 28(7):2179-2193. PubMed ID: 33649470
[TBL] [Abstract][Full Text] [Related]
34. Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.
Russell P; Hennessy BT; Li J; Carey MS; Bast RC; Freeman T; Venkitaraman AR
Oncogene; 2012 May; 31(19):2450-60. PubMed ID: 22056875
[TBL] [Abstract][Full Text] [Related]
35. Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold.
Galán-Malo P; Vela L; Gonzalo O; Calvo-Sanjuán R; Gracia-Fleta L; Naval J; Marzo I
Toxicol Appl Pharmacol; 2012 Feb; 258(3):384-93. PubMed ID: 22178383
[TBL] [Abstract][Full Text] [Related]
36. Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.
Harrison MR; Holen KD; Liu G
Clin Adv Hematol Oncol; 2009 Jan; 7(1):54-64. PubMed ID: 19274042
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale.
Komlodi-Pasztor E; Sackett DL; Fojo AT
Clin Cancer Res; 2012 Jan; 18(1):51-63. PubMed ID: 22215906
[TBL] [Abstract][Full Text] [Related]
38. Mitotic checkpoint defects: en route to cancer and drug resistance.
Sarkar S; Sahoo PK; Mahata S; Pal R; Ghosh D; Mistry T; Ghosh S; Bera T; Nasare VD
Chromosome Res; 2021 Jun; 29(2):131-144. PubMed ID: 33409811
[TBL] [Abstract][Full Text] [Related]
39. BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death.
Huang S; Tang R; Poon RY
Oncotarget; 2016 Jun; 7(25):38718-38730. PubMed ID: 27231850
[TBL] [Abstract][Full Text] [Related]
40. Chromosome alignment-maintaining phosphoprotein CHAMP1 plays a role in cell survival through regulating Mcl-1 expression.
Hino M; Iemura K; Ikeda M; Itoh G; Tanaka K
Cancer Sci; 2021 Sep; 112(9):3711-3721. PubMed ID: 34107118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
